RPL19

RPL19 (eL19) is a structural protein of the 60S large ribosomal subunit that mediates 80S ribosome assembly and intersubunit joining (PMID:27038511). Its C-terminal α-helix forms the eukaryote-specific eB12 intersubunit bridge through contacts with 18S rRNA and the ribosomal proteins eS7/uS17, and 60S subunits carrying eB12-defective eL19 variants fail to associate with 40S subunits regardless of Mg2+ concentration; the globular and middle domains are independently required for viability and ribosome assembly (PMID:27038511). Its surface accessibility on the assembled ribosome makes EGFP-tagged RPL19 an efficient affinity handle for translating-ribosome purification (TRAP) (PMID:40042546). Beyond translation, RPL19 carries out extra-ribosomal regulatory functions: its depletion selectively reshapes transcription-factor and cell-adhesion gene networks and abrogates tumor xenograft growth without altering proliferation or apoptosis in vitro (PMID:21799931), and in HER2-amplified breast cancer it drives tumor proliferation, migration, invasion, and trastuzumab resistance by upregulating IL-4 via the transcription factor JUN, activating IL-4/p-STAT6 signaling and suppressing macrophage phagocytosis of tumor cells (PMID:41723529). RPL19 protein is degraded through autophagy downstream of PI3K/mTOR inhibition, contributing to drug-induced G2/M arrest and tumor suppression (PMID:40771929).

1. 1995 Medium

   Established the genomic and transcriptional identity of RPL19, showing its expression depends on regulatory architecture distinct from other ribosomal protein genes.

   Evidence FISH chromosomal mapping and promoter deletion analysis of rat and human RPL19 genes

   PMID:7789970

   Open questions at the time

   • Did not identify the trans-acting factors binding the far-upstream sequences
   • No link between transcriptional regulation and protein function
2. 2011 Medium

   Revealed that RPL19 has extra-ribosomal regulatory roles, since its knockdown blocked tumor growth in vivo and remodeled transcription-factor/adhesion gene networks without affecting basal proliferation or apoptosis.

   Evidence siRNA knockdown with gene expression arrays and prostate cancer xenografts

   PMID:21799931

   Open questions at the time

   • Direct molecular targets mediating the network changes not defined
   • Mechanism separating extra-ribosomal from translational function unresolved
3. 2016 High

   Defined the structural role of RPL19 in ribosome biogenesis, showing its C-terminal α-helix forms the eB12 intersubunit bridge required for 80S formation.

   Evidence Deletion mutagenesis in yeast plus in vitro subunit reassociation and phenotypic assays

   PMID:27038511

   Open questions at the time

   • Based on yeast eL19; human-specific structural confirmation not shown in corpus
   • Functional consequence of eB12 disruption on translational fidelity not detailed
4. 2016 Low

   Identified a candidate physical partner (ERH), raising the possibility that RPL19 contributes to nuclear targeting of an interacting protein.

   Evidence Yeast two-hybrid screen and deletion domain mapping in Drosophila

   PMID:27830090

   Open questions at the time

   • Single yeast two-hybrid assay without reciprocal co-IP or in vivo validation
   • Proposed role in ERH nuclear localization not tested directly
5. 2025 Medium

   Connected RPL19 abundance to drug response by showing it is degraded via autophagy after PI3K/mTOR inhibition, contributing to cell cycle arrest and tumor suppression.

   Evidence NVP-BEZ235 treatment of nephroblastoma cells with autophagic flux assays and in vivo RPL19 overexpression rescue

   PMID:40771929

   Open questions at the time

   • Autophagy receptor selecting RPL19 for degradation unknown
   • Whether degraded pool is ribosomal or free RPL19 not distinguished
6. 2025 Medium

   Exploited RPL19's exposed position on the large subunit as an optimal TRAP tag for purifying translating ribosomes and profiling translated mRNA.

   Evidence CRISPR knock-in of EGFP-RPL19, TRAP immunoprecipitation, and sequencing with rapamycin validation

   PMID:40042546

   Open questions at the time

   • A methodological application rather than new mechanistic function
   • Did not address whether tagging perturbs ribosome function
7. 2026 Medium

   Defined a signaling cascade for RPL19's pro-tumor activity, showing it upregulates IL-4 through JUN to activate IL-4/p-STAT6 signaling and suppress macrophage phagocytosis.

   Evidence In vitro proliferation/migration/invasion assays, in vivo tumor models, and macrophage phagocytosis assays in HER2-amplified breast cancer

   PMID:41723529

   Open questions at the time

   • How RPL19 mechanistically controls JUN activity not resolved
   • Single lab without independent replication

• It remains unresolved how RPL19's structural ribosomal role mechanistically relates to its extra-ribosomal transcriptional and tumor-promoting activities.
• No structural or biochemical link between free RPL19 and gene-network regulation
• Direct molecular targets of extra-ribosomal RPL19 unidentified